SUNPHARMA — Sun Pharmaceutical Industries Income Statement
0.000.00%
Last trade - 00:00
- IN₹3.65tn
- IN₹3.55tn
- IN₹438.86bn
- 96
- 12
- 98
- 84
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 290,659 | 328,375 | 334,981 | 386,545 | 438,857 |
Cost of Revenue | |||||
Gross Profit | 198,272 | 223,662 | 236,127 | 269,468 | 319,433 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 253,782 | 281,291 | 313,515 | 350,768 | 347,933 |
Operating Profit | 36,877 | 47,084 | 21,466 | 35,777 | 90,924 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 38,102 | 50,096 | 27,994 | 44,813 | 94,084 |
Provision for Income Taxes | |||||
Net Income After Taxes | 32,093 | 41,868 | 22,847 | 34,058 | 85,608 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 26,654 | 37,649 | 29,038 | 32,727 | 84,736 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 26,654 | 37,649 | 29,038 | 32,727 | 84,736 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 15.6 | 16.5 | 26.7 | 28 | 36 |
Dividends per Share |